Nanjing Vazyme Biotech Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Nanjing Vazyme Biotech has a total shareholder equity of CN¥3.9B and total debt of CN¥500.9M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥4.9B and CN¥959.4M respectively.
Belangrijke informatie
12.7%
Verhouding schuld/eigen vermogen
CN¥500.92m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥2.47b |
| Aandelen | CN¥3.94b |
| Totaal verplichtingen | CN¥959.43m |
| Totaal activa | CN¥4.90b |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: 688105's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥731.2M).
Langlopende schulden: 688105's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥228.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688105 has more cash than its total debt.
Schuld verminderen: 688105's debt to equity ratio has reduced from 18% to 12.7% over the past 5 years.
Schuldendekking: 688105's debt is not well covered by operating cash flow (14.3%).
Rentedekking: Insufficient data to determine if 688105's interest payments on its debt are well covered by EBIT.